Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04223609 · ClinicalTrials.gov registry record · Phase 1
Non-intrusive Detection of Temporary Neurologic Impairment By Opioids
A Phase 1 study of Healthy, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04223609: Completed Phase 1 study of Healthy, sponsored by Mayo Clinic.
NCT04223609 is a Phase 1 study of Healthy that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04223609, a Phase 1 study of Healthy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Research is being conducted to better understand the physiologic effects (relating to the action of a drug when taken by a healthy person) of opioid use on oculomotor (relating to the motion of the eye) dynamics and to identify the presence of characteristics consistent with a specific drug or class of drugs.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxycodone
- DEVICE EyeLink 1000 Plus
- DIAGNOSTIC_TEST Oculo-Cognitive Addition test (OCAT)
- DEVICE VT3mini - Eye Tracking Technology for OEMs
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2022-04-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04223609
The ClinicalTrials.gov registry entry for NCT04223609 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT04223609 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04223609 about?
NCT04223609 is a clinical study titled "Non-intrusive Detection of Temporary Neurologic Impairment By Opioids". Research is being conducted to better understand the physiologic effects (relating to the action of a drug when taken by a healthy person) of opioid use on oculomotor (relating to the motion of the eye) dynamics and to identify the presence of characteristics consistent with a specific drug or class...
What is the current status of trial NCT04223609?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2020-02-28. Estimated completion is 2022-04-11.
What conditions does trial NCT04223609 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT04223609?
The interventions under investigation include: Placebo (DRUG), Oxycodone (DRUG), EyeLink 1000 Plus (DEVICE), Oculo-Cognitive Addition test (OCAT) (DIAGNOSTIC_TEST), VT3mini - Eye Tracking Technology for OEMs (DEVICE).
Who is sponsoring clinical trial NCT04223609?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04223609 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
RECRUITING · Phase 1
-
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
RECRUITING · Phase 1
-
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
RECRUITING · Phase 1
-
A Study of V118E in Healthy Participants (V118E-003)
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.